Mastodynon

Medicinal product

(Invented) name

Mastodynon

Active substance (s)

Agnus castus Ø/Caulophyllum thalictroides D4/Cyclamen D4/Ignatia D6/Iris D2/Lilium tigrinum D3

Strength

162 mg/81 mg/81 mg/81 mg/162 mg/81 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2023-02-21

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Agnus castus Ø	162 mg
Caulophyllum thalictroides D4	81 mg
Cyclamen D4	81 mg
Ignatia D6	81 mg
Iris D2	162 mg
Lilium tigrinum D3	81 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
110450	96560	1096560	lizdinė plokštelė	N60		Nereceptinis	LT/L/23/1834/001	Tiekiama	-	-	No	-	-	Download
110451	96561	1096561	lizdinė plokštelė	N120		Nereceptinis	LT/L/23/1834/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-02-21	Registruotas